Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 9/2014

01.09.2014 | Review

Infections and systemic lupus erythematosus

verfasst von: S. Esposito, S. Bosis, M. Semino, D. Rigante

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that presents a protean spectrum of clinical manifestations, and may affect any organ. The typical course of SLE is insidious, slow, and progressive, with potential exacerbations and remissions, and even dramatically acute and rapidly fatal outcomes. Recently, infections have been shown to be highly associated with the onset and/or exacerbations of SLE, and their possible causative and/or protective role has been largely emphasized in the medical literature. However, the etiopathogenesis of SLE is still obscure and far from being completely elucidated. Among infections, particularly Epstein–Barr virus (EBV), parvovirus B19, retrovirus, and cytomegalovirus (CMV) infections might play a pivotal pathogenetic role. The multifaceted interactions between infections and autoimmunity reveal many possibilities for either causative or protective associations. Indeed, some infections, primarily protozoan infections, might confer protection from autoimmune processes, depending on the unique interaction between the microorganism and host. Further studies are needed in order to demonstrate that infectious agents might, indeed, be causative of SLE, and to address the potential clinical sequelae of infections in the field of autoimmunity.
Literatur
1.
Zurück zum Zitat Draborg AH, Duus K, Houen G (2013) Epstein–Barr virus and systemic lupus erythematosus. Clin Dev Immunol 2013:1–10 Draborg AH, Duus K, Houen G (2013) Epstein–Barr virus and systemic lupus erythematosus. Clin Dev Immunol 2013:1–10
2.
Zurück zum Zitat Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929–939PubMed Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929–939PubMed
3.
Zurück zum Zitat Habibi S, Saleem MA, Ramanan AV (2011) Juvenile systemic lupus erythematosus: review of clinical features and management. Indian Pediatr 48:879–887PubMed Habibi S, Saleem MA, Ramanan AV (2011) Juvenile systemic lupus erythematosus: review of clinical features and management. Indian Pediatr 48:879–887PubMed
4.
Zurück zum Zitat O’Neill S, Cervera R (2010) Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 24:841–855PubMed O’Neill S, Cervera R (2010) Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 24:841–855PubMed
5.
Zurück zum Zitat Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L et al (2009) Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68:412–415PubMed Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L et al (2009) Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 68:412–415PubMed
6.
Zurück zum Zitat Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706PubMed Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P et al (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:700–706PubMed
7.
Zurück zum Zitat Petty RE, Laxer RM (2005) Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology. Elsevier Saunders, Philadelphia, pp 342–391 Petty RE, Laxer RM (2005) Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology. Elsevier Saunders, Philadelphia, pp 342–391
8.
Zurück zum Zitat Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556–562PubMed Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556–562PubMed
9.
Zurück zum Zitat Samanta A, Roy S, Feehally J, Symmons DP (1992) The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol 31:679–682PubMed Samanta A, Roy S, Feehally J, Symmons DP (1992) The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol 31:679–682PubMed
10.
Zurück zum Zitat Serdula MK, Rhoads GG (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22:328–333PubMed Serdula MK, Rhoads GG (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22:328–333PubMed
11.
Zurück zum Zitat Huang JL, Yao TC, See LC (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22:776–780PubMed Huang JL, Yao TC, See LC (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22:776–780PubMed
12.
Zurück zum Zitat Kurahara DK, Grandinetti A, Fujii LL, Tokuda AA, Galario JA, Han MJ et al (2007) Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol 34:425–429PubMed Kurahara DK, Grandinetti A, Fujii LL, Tokuda AA, Galario JA, Han MJ et al (2007) Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol 34:425–429PubMed
13.
Zurück zum Zitat Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V (1989) Systemic lupus erythematosus in the first decade of life. Pediatrics 83:235–239PubMed Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V (1989) Systemic lupus erythematosus in the first decade of life. Pediatrics 83:235–239PubMed
14.
Zurück zum Zitat Taddio A, Rossetto E, Rosé CD, Brescia AM, Bracaglia C, Cortis E et al (2010) Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: results from a multicenter study. J Pediatr 156:972–977PubMed Taddio A, Rossetto E, Rosé CD, Brescia AM, Bracaglia C, Cortis E et al (2010) Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: results from a multicenter study. J Pediatr 156:972–977PubMed
15.
Zurück zum Zitat Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S et al (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459PubMedCentralPubMed Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S et al (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459PubMedCentralPubMed
16.
Zurück zum Zitat Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC et al (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226PubMed Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC et al (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226PubMed
17.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
18.
Zurück zum Zitat Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686PubMedCentralPubMed Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686PubMedCentralPubMed
19.
Zurück zum Zitat Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y (2012) Environment and lupus-related diseases. Lupus 21:241–250PubMed Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y (2012) Environment and lupus-related diseases. Lupus 21:241–250PubMed
20.
Zurück zum Zitat Rigante D, Mazzoni MB, Esposito S (2014) The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 13:96–102PubMed Rigante D, Mazzoni MB, Esposito S (2014) The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 13:96–102PubMed
21.
Zurück zum Zitat Barzilai O, Ram M, Shoenfeld Y (2007) Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 19:636–643PubMed Barzilai O, Ram M, Shoenfeld Y (2007) Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 19:636–643PubMed
22.
Zurück zum Zitat Sebastiani GD, Galeazzi M (2009) Infection—genetics relationship in systemic lupus erythematosus. Lupus 18:1169–1175PubMed Sebastiani GD, Galeazzi M (2009) Infection—genetics relationship in systemic lupus erythematosus. Lupus 18:1169–1175PubMed
23.
Zurück zum Zitat Sciascia S, Ceberio L, Garcia-Fernandez C, Roccatello D, Karim Y, Cuadrado MJ (2012) Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev 12:157–163PubMed Sciascia S, Ceberio L, Garcia-Fernandez C, Roccatello D, Karim Y, Cuadrado MJ (2012) Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev 12:157–163PubMed
24.
Zurück zum Zitat Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12:426–429PubMed Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12:426–429PubMed
25.
Zurück zum Zitat Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y (2007) Epstein–Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108:567–577PubMed Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y (2007) Epstein–Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108:567–577PubMed
26.
Zurück zum Zitat Koutouzov S, Mathian A, Dalloul A (2006) Type-I interferons and systemic lupus erythematosus. Autoimmun Rev 5:554–562PubMed Koutouzov S, Mathian A, Dalloul A (2006) Type-I interferons and systemic lupus erythematosus. Autoimmun Rev 5:554–562PubMed
27.
Zurück zum Zitat Santana-de Anda K, Gómez-Martín D, Díaz-Zamudio M, Alcocer-Varela J (2011) Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmun Rev 11:98–103PubMed Santana-de Anda K, Gómez-Martín D, Díaz-Zamudio M, Alcocer-Varela J (2011) Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmun Rev 11:98–103PubMed
28.
Zurück zum Zitat Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y et al (2006) DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 6:99–106PubMed Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y et al (2006) DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 6:99–106PubMed
29.
Zurück zum Zitat Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity—friends or foes? Trends Immunol 30:409–414PubMed Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity—friends or foes? Trends Immunol 30:409–414PubMed
30.
Zurück zum Zitat Arbuckle MR, Gross T, Scofield RH, Hinshaw LB, Chang AC, Taylor FB Jr et al (1998) Lupus humoral autoimmunity induced in a primate model by short peptide immunization. J Invest Med 46:58–65 Arbuckle MR, Gross T, Scofield RH, Hinshaw LB, Chang AC, Taylor FB Jr et al (1998) Lupus humoral autoimmunity induced in a primate model by short peptide immunization. J Invest Med 46:58–65
31.
Zurück zum Zitat Edwards CJ, Syddall H, Goswami R, Goswami P, Dennison EM, Cooper C (2006) Infections in infancy and the presence of antinuclear antibodies in adult life. Lupus 15:213–217PubMed Edwards CJ, Syddall H, Goswami R, Goswami P, Dennison EM, Cooper C (2006) Infections in infancy and the presence of antinuclear antibodies in adult life. Lupus 15:213–217PubMed
32.
Zurück zum Zitat Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Ram M, Anaya JM et al (2008) Neuropsychiatric lupus and infectious triggers. Lupus 17:380–384PubMed Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Ram M, Anaya JM et al (2008) Neuropsychiatric lupus and infectious triggers. Lupus 17:380–384PubMed
33.
Zurück zum Zitat Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M et al (2009) Exposure to Epstein–Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 1173:658–663PubMed Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M et al (2009) Exposure to Epstein–Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 1173:658–663PubMed
34.
Zurück zum Zitat Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y (2008) The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30:37–41PubMed Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y (2008) The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30:37–41PubMed
35.
Zurück zum Zitat Keynan Y, Card CM, McLaren PJ, Dawood MR, Kasper K, Fowke KR (2008) The role of regulatory T cells in chronic and acute viral infections. Clin Infect Dis 46:1046–1052PubMed Keynan Y, Card CM, McLaren PJ, Dawood MR, Kasper K, Fowke KR (2008) The role of regulatory T cells in chronic and acute viral infections. Clin Infect Dis 46:1046–1052PubMed
36.
Zurück zum Zitat Bopp T, Jonuleit H, Schmitt E (2007) Regulatory T cells—the renaissance of the suppressor T cells. Ann Med 39:322–334PubMed Bopp T, Jonuleit H, Schmitt E (2007) Regulatory T cells—the renaissance of the suppressor T cells. Ann Med 39:322–334PubMed
37.
Zurück zum Zitat Doria A, Sarzi-Puttini P, Shoenfeld Y (2008) Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 8:1–4PubMed Doria A, Sarzi-Puttini P, Shoenfeld Y (2008) Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 8:1–4PubMed
39.
Zurück zum Zitat Evans AS (1971) E.B. virus antibody in systemic lupus erythematosus. Lancet 1:1023–1024PubMed Evans AS (1971) E.B. virus antibody in systemic lupus erythematosus. Lancet 1:1023–1024PubMed
40.
Zurück zum Zitat de Carvalho JF, Pereira RM, Shoenfeld Y (2009) The mosaic of autoimmunity: the role of environmental factors. Front Biosci (Elite Ed) 1:501–509 de Carvalho JF, Pereira RM, Shoenfeld Y (2009) The mosaic of autoimmunity: the role of environmental factors. Front Biosci (Elite Ed) 1:501–509
41.
Zurück zum Zitat James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein–Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019–3026PubMedCentralPubMed James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein–Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019–3026PubMedCentralPubMed
42.
Zurück zum Zitat Gergely P Jr, Pullmann R, Stancato C, Otvos L Jr, Koncz A, Blazsek A et al (2005) Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol 116:124–134PubMed Gergely P Jr, Pullmann R, Stancato C, Otvos L Jr, Koncz A, Blazsek A et al (2005) Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol 116:124–134PubMed
43.
Zurück zum Zitat James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure. Arthritis Rheum 44:1122–1126PubMed James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure. Arthritis Rheum 44:1122–1126PubMed
44.
45.
Zurück zum Zitat Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH et al (2004) Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood. Arthritis Res Ther 6:R295–R302PubMedCentralPubMed Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH et al (2004) Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood. Arthritis Res Ther 6:R295–R302PubMedCentralPubMed
46.
Zurück zum Zitat Zandman-Goddard G, Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38:473–485PubMed Zandman-Goddard G, Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38:473–485PubMed
47.
Zurück zum Zitat Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J et al (2004) Defective control of latent Epstein–Barr virus infection in systemic lupus erythematosus. J Immunol 172:1287–1294PubMed Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J et al (2004) Defective control of latent Epstein–Barr virus infection in systemic lupus erythematosus. J Immunol 172:1287–1294PubMed
48.
Zurück zum Zitat Blank M, Shoenfeld Y, Perl A (2009) Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus 18:1136–1143PubMed Blank M, Shoenfeld Y, Perl A (2009) Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus 18:1136–1143PubMed
49.
Zurück zum Zitat Poole BD, Scofield RH, Harley JB, James JA (2006) Epstein–Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39:63–70PubMed Poole BD, Scofield RH, Harley JB, James JA (2006) Epstein–Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39:63–70PubMed
50.
Zurück zum Zitat Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW et al (2005) Association of Epstein–Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148–1159PubMed Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW et al (2005) Association of Epstein–Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148–1159PubMed
51.
Zurück zum Zitat Tugnet N, Rylance P, Roden D, Trela M, Nelson P (2013) Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? Open Rheumatol J 7:13–21PubMedCentralPubMed Tugnet N, Rylance P, Roden D, Trela M, Nelson P (2013) Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? Open Rheumatol J 7:13–21PubMedCentralPubMed
52.
Zurück zum Zitat Pullmann R Jr, Bonilla E, Phillips PE, Middleton FA, Perl A (2008) Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 58:532–540PubMed Pullmann R Jr, Bonilla E, Phillips PE, Middleton FA, Perl A (2008) Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 58:532–540PubMed
53.
Zurück zum Zitat Yoshiki T, Mellors RC, Strand M, August JT (1974) The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 140:1011–1027PubMedCentralPubMed Yoshiki T, Mellors RC, Strand M, August JT (1974) The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 140:1011–1027PubMedCentralPubMed
54.
Zurück zum Zitat Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, Doherty E et al (2008) Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity 41:287–297PubMed Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, Doherty E et al (2008) Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity 41:287–297PubMed
55.
Zurück zum Zitat Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K et al (1995) Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 38:1660–1671PubMed Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K et al (1995) Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 38:1660–1671PubMed
56.
Zurück zum Zitat Perl A, Fernandez D, Telarico T, Phillips PE (2010) Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol 22:483–492PubMed Perl A, Fernandez D, Telarico T, Phillips PE (2010) Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol 22:483–492PubMed
57.
Zurück zum Zitat Gergely P Jr, Perl A, Poór G (2006) Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases? Autoimmun Rev 6:5–9PubMed Gergely P Jr, Perl A, Poór G (2006) Possible pathogenic nature of the recently discovered TT virus: does it play a role in autoimmune rheumatic diseases? Autoimmun Rev 6:5–9PubMed
58.
Zurück zum Zitat Emlen W, Niebur J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685–3692PubMed Emlen W, Niebur J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685–3692PubMed
59.
Zurück zum Zitat Pavlovic M, Kats A, Cavallo M, Shoenfeld Y (2010) Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 19:783–792PubMed Pavlovic M, Kats A, Cavallo M, Shoenfeld Y (2010) Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 19:783–792PubMed
60.
Zurück zum Zitat Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C (2008) Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Eur J Intern Med 19:314–318PubMed Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C (2008) Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Eur J Intern Med 19:314–318PubMed
61.
Zurück zum Zitat Hayashi T, Lee S, Ogasawara H, Sekigawa I, Iida N, Tomino Y et al (1998) Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 7:561–564PubMed Hayashi T, Lee S, Ogasawara H, Sekigawa I, Iida N, Tomino Y et al (1998) Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 7:561–564PubMed
62.
Zurück zum Zitat Nawata M, Seta N, Yamada M, Sekigawa I, Lida N, Hashimoto H (2001) Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol 30:360–362PubMed Nawata M, Seta N, Yamada M, Sekigawa I, Lida N, Hashimoto H (2001) Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol 30:360–362PubMed
63.
Zurück zum Zitat Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V et al (1999) Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 82:145–154PubMed Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V et al (1999) Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 82:145–154PubMed
64.
Zurück zum Zitat Ramos-Casals M, Font J, García-Carrasco M, Cervera R, Jiménez S, Trejo O et al (2000) Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 43:2801–2806PubMed Ramos-Casals M, Font J, García-Carrasco M, Cervera R, Jiménez S, Trejo O et al (2000) Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 43:2801–2806PubMed
65.
Zurück zum Zitat Karakoç Y, Dilek K, Güllülü M, Yavuz M, Ersoy A, Akalyn H et al (1997) Prevalence of hepatitis C virus antibody in patients with systemic lupus erythematosus. Ann Rheum Dis 56:570–571PubMedCentralPubMed Karakoç Y, Dilek K, Güllülü M, Yavuz M, Ersoy A, Akalyn H et al (1997) Prevalence of hepatitis C virus antibody in patients with systemic lupus erythematosus. Ann Rheum Dis 56:570–571PubMedCentralPubMed
66.
Zurück zum Zitat Mercado U, Avendaño-Reyes M, Araiza-Casillas R, Díaz-Molina R (2005) Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus. Rev Gastroenterol Mex 70:399–401PubMed Mercado U, Avendaño-Reyes M, Araiza-Casillas R, Díaz-Molina R (2005) Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus. Rev Gastroenterol Mex 70:399–401PubMed
67.
Zurück zum Zitat Green NM, Marshak-Rothstein A (2011) Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23:106–112PubMedCentralPubMed Green NM, Marshak-Rothstein A (2011) Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23:106–112PubMedCentralPubMed
68.
Zurück zum Zitat Pisetsky DS (2008) The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 8:69–72PubMed Pisetsky DS (2008) The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 8:69–72PubMed
69.
Zurück zum Zitat Corthésy B (2013) Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 12:661–665PubMed Corthésy B (2013) Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 12:661–665PubMed
70.
Zurück zum Zitat Kim WU, Sreih A, Bucala R (2009) Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev 8:204–208PubMedCentralPubMed Kim WU, Sreih A, Bucala R (2009) Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev 8:204–208PubMedCentralPubMed
71.
Zurück zum Zitat Münz C, Lünemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246–258PubMedCentralPubMed Münz C, Lünemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246–258PubMedCentralPubMed
72.
Zurück zum Zitat Fischer S, Agmon-Levin N, Shapira Y, Porat Katz BS, Graell E, Cervera R et al (2013) Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunol Res 56:287–292PubMed Fischer S, Agmon-Levin N, Shapira Y, Porat Katz BS, Graell E, Cervera R et al (2013) Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunol Res 56:287–292PubMed
73.
Zurück zum Zitat Vercelli D (2006) Mechanisms of the hygiene hypothesis—molecular and otherwise. Curr Opin Immunol 18:733–737PubMed Vercelli D (2006) Mechanisms of the hygiene hypothesis—molecular and otherwise. Curr Opin Immunol 18:733–737PubMed
74.
Zurück zum Zitat Zandman-Goddard G, Shoenfeld Y (2009) Parasitic infection and autoimmunity. Lupus 18:1144–1148PubMed Zandman-Goddard G, Shoenfeld Y (2009) Parasitic infection and autoimmunity. Lupus 18:1144–1148PubMed
75.
Zurück zum Zitat Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N et al (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A 104:7169–7174PubMedCentralPubMed Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N et al (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A 104:7169–7174PubMedCentralPubMed
76.
Zurück zum Zitat Greenwood B, Corrah T (2001) Systemic lupus erythematosus in African immigrants. Lancet 358:1182PubMed Greenwood B, Corrah T (2001) Systemic lupus erythematosus in African immigrants. Lancet 358:1182PubMed
77.
Zurück zum Zitat Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S et al (2004) Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black × New Zealand White) F1 mice. Int Immunol 16:937–946PubMed Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S et al (2004) Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black × New Zealand White) F1 mice. Int Immunol 16:937–946PubMed
78.
Zurück zum Zitat Harnett W, Harnett MM (2006) Molecular basis of worm-induced immunomodulation. Parasite Immunol 28:535–543PubMed Harnett W, Harnett MM (2006) Molecular basis of worm-induced immunomodulation. Parasite Immunol 28:535–543PubMed
79.
Zurück zum Zitat Liu G, Zhao Y (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122:149–156PubMedCentralPubMed Liu G, Zhao Y (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122:149–156PubMedCentralPubMed
80.
Zurück zum Zitat Bach JF (2001) Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun 16:347–353PubMed Bach JF (2001) Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun 16:347–353PubMed
81.
Zurück zum Zitat Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB (2004) Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 31:1546–1550PubMed Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB (2004) Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 31:1546–1550PubMed
82.
Zurück zum Zitat Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y et al (2008) Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 26:S27–S32PubMed Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y et al (2008) Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 26:S27–S32PubMed
83.
Zurück zum Zitat Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M et al (2008) The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 7:621–625PubMed Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M et al (2008) The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 7:621–625PubMed
84.
Zurück zum Zitat Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E et al (2007) Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15:823–830PubMed Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E et al (2007) Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15:823–830PubMed
85.
Zurück zum Zitat Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US et al (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8PubMed Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US et al (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8PubMed
86.
Zurück zum Zitat Van Ghelue M, Moens U, Bendiksen S, Rekvig OP (2003) Autoimmunity to nucleosomes related to viral infection: a focus on hapten–carrier complex formation. J Autoimmun 20:171–182PubMed Van Ghelue M, Moens U, Bendiksen S, Rekvig OP (2003) Autoimmunity to nucleosomes related to viral infection: a focus on hapten–carrier complex formation. J Autoimmun 20:171–182PubMed
87.
Zurück zum Zitat Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008. Isr Med Assoc J 10:3–7PubMed Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008. Isr Med Assoc J 10:3–7PubMed
88.
Zurück zum Zitat Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I et al (2006) Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 54:3601–3611PubMed Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I et al (2006) Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 54:3601–3611PubMed
89.
Zurück zum Zitat Garred P, Voss A, Madsen HO, Junker P (2001) Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2:442–450PubMed Garred P, Voss A, Madsen HO, Junker P (2001) Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2:442–450PubMed
90.
Zurück zum Zitat Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285PubMed Walport MJ, Davies KA, Botto M (1998) C1q and systemic lupus erythematosus. Immunobiology 199:265–285PubMed
91.
Zurück zum Zitat Aron-Maor A, Shoenfeld Y (2001) Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 10:237–240PubMed Aron-Maor A, Shoenfeld Y (2001) Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 10:237–240PubMed
92.
Zurück zum Zitat Dell’ Era L, Esposito S, Corona F, Principi N (2011) Vaccination of children and adolescents with rheumatic diseases. Rheumatology (Oxford) 50:1358–1365 Dell’ Era L, Esposito S, Corona F, Principi N (2011) Vaccination of children and adolescents with rheumatic diseases. Rheumatology (Oxford) 50:1358–1365
93.
Zurück zum Zitat Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R et al (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24:3217–3223PubMed Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R et al (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24:3217–3223PubMed
94.
Zurück zum Zitat Hidalgo-Tenorio C, Jiménez-Alonso J, de Dios Luna J, Tallada M, Martínez-Brocal A, Sabio JM (2004) Urinary tract infections and lupus erythematosus. Ann Rheum Dis 63:431–437PubMedCentralPubMed Hidalgo-Tenorio C, Jiménez-Alonso J, de Dios Luna J, Tallada M, Martínez-Brocal A, Sabio JM (2004) Urinary tract infections and lupus erythematosus. Ann Rheum Dis 63:431–437PubMedCentralPubMed
95.
Zurück zum Zitat Gladman DD, Hussain F, Ibañez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234–239PubMed Gladman DD, Hussain F, Ibañez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234–239PubMed
96.
Zurück zum Zitat Hill MD, Karsh J (1997) Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: case report and review of the literature. Arthitis Rheum 40:1716–1719 Hill MD, Karsh J (1997) Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: case report and review of the literature. Arthitis Rheum 40:1716–1719
97.
Zurück zum Zitat Marcos M, Fernández C, Soriano A, Marco F, Martínez JA, Almela M et al (2011) Epidemiology and clinical outcomes of bloodstream infections among lupus patients. Lupus 20:965–971PubMed Marcos M, Fernández C, Soriano A, Marco F, Martínez JA, Almela M et al (2011) Epidemiology and clinical outcomes of bloodstream infections among lupus patients. Lupus 20:965–971PubMed
98.
Zurück zum Zitat Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Aguirre C (2006) High risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235PubMed Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Aguirre C (2006) High risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235PubMed
99.
Zurück zum Zitat Mok MY, Wong SS, Chan TM, Fong DY, Wong WS, Lau CS (2007) Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 46:280–284 Mok MY, Wong SS, Chan TM, Fong DY, Wong WS, Lau CS (2007) Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 46:280–284
100.
Zurück zum Zitat Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH (1997) Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 15:405–409PubMed Rider JR, Ollier WE, Lock RJ, Brookes ST, Pamphilon DH (1997) Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 15:405–409PubMed
101.
Zurück zum Zitat Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L et al (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87:311–318 Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L et al (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87:311–318
102.
Zurück zum Zitat Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMed Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMed
103.
Zurück zum Zitat Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286–1294PubMed Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286–1294PubMed
104.
Zurück zum Zitat Bosch X, Guilabert A, Pallarés L, Cerveral R, Ramos-Casals M, Bové A et al (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584–589PubMed Bosch X, Guilabert A, Pallarés L, Cerveral R, Ramos-Casals M, Bové A et al (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584–589PubMed
105.
Zurück zum Zitat Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study. Ann Rheum Dis 70:956–960PubMedCentralPubMed Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study. Ann Rheum Dis 70:956–960PubMedCentralPubMed
106.
Zurück zum Zitat Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A et al (2011) Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. Arthritis Res Ther 13:R112PubMedCentralPubMed Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A et al (2011) Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. Arthritis Res Ther 13:R112PubMedCentralPubMed
107.
Zurück zum Zitat Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377:721–731PubMed Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377:721–731PubMed
108.
Zurück zum Zitat Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Muñoz S et al (2008) Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus 17:281–288PubMed Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Muñoz S et al (2008) Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus 17:281–288PubMed
Metadaten
Titel
Infections and systemic lupus erythematosus
verfasst von
S. Esposito
S. Bosis
M. Semino
D. Rigante
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2098-7

Weitere Artikel der Ausgabe 9/2014

European Journal of Clinical Microbiology & Infectious Diseases 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.